STAAR Surgical Company (NASDAQ: STAA) shares touched a new 52-week low of $9.50 on Q3 results. Canaccord Genuity downgraded STAAR Surgical from Buy to Hold and lowered the price target from $16.00 to $12.00.
Trimble Navigation (NASDAQ: TRMB)...
Analysts at JMP Securities downgraded Regional Management (NYSE: RM) from Market Outperform to Market Perform and removed the price target of $21.00. Regional Management's shares closed at $17.99 yesterday.
Analysts at Pacific Crest downgraded...
Analysts at Canaccord Genuity downgraded STAAR Surgical Company (NASDAQ: STAA) from Buy to Hold.
The price target for STAAR Surgical Company has been lowered from $16.00 to $12.00.
STAAR Surgical Company shares have dropped 16.62% over the...
The securities litigation law firm of Brower Piven, A Professional
Corporation, announces that a class action lawsuit has been commenced in
the United States District Court for the Central District of California
on behalf of...
STAAR Surgical Company (NASDAQ:STAA)
Q2 2014 Earnings Conference Call
July 31, 2014 5:00 PM ET
Doug Sherk – EVC Group
Barry Caldwell – President & CEO
Steve Brown – CFO
Deborah Andrews – Chief Accounting...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to STAAR Surgical Company (STAA):